Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

Hagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, Partow Kebriaei, Elias Jabbour, Michael Rytting, Sergernne York, Farhad Ravandi, Rebecca Garris, Monica Kwari, Stefan Faderl, Jorge Cortes, Richard Champlin, Susan O'Brien

Research output: Contribution to journalArticlepeer-review

206 Scopus citations

Fingerprint

Dive into the research topics of 'Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences